Therapeutic Research Protocol Dose: 0.5 0.75 mg (variant 5 mg pen = 2030 clicks / variant 10 mg pen = 1015 clicks) Duration: 4 6 weeks Frequency: Daily Cycle Interval: 4 weeks off before next cycle Goal / Description: Used in muscle or tendon repair studies
Safety and Compliance California Proposition 65 Warning : This product may expose you to chemicals known to cause cancer, birth defects, or other reproductive harm
This work was funded by: TS (Baylor College of Medicine, U01-AI24290, P01-AI152999, NINR R01-NR013497, and NIDDK P30-DK56338), SJW (NIDDK 1R41DK119052-01 and NIA P30-AG024832 [PI: E
Additionally, BPC-157 appears to influence nitric oxide synthase activity, thereby affecting vascular tone and tissue perfusion, which are critical components of the healing response
Required supplies Your GHK-Cu vial contains lyophilized (freeze-dried) powder, typically 50mg or 100mg quantities